DE SB38 | 2015-2016 | 148th General Assembly
Status
Spectrum: Moderate Partisan Bill (Republican 13-2)
Status: Introduced on March 24 2015 - 25% progression, died in committee
Action: 2015-03-24 - Assigned to Health & Social Services Committee in Senate
Pending: Senate Health & Social Services Committee
Text: Latest bill text (Draft #1) [HTML]
Status: Introduced on March 24 2015 - 25% progression, died in committee
Action: 2015-03-24 - Assigned to Health & Social Services Committee in Senate
Pending: Senate Health & Social Services Committee
Text: Latest bill text (Draft #1) [HTML]
Summary
This legislation is modeled after “Right to Try” legislation, which has been enacted in Colorado and Louisiana, awaiting gubernatorial action in Missouri, introduced in Minnesota, New Jersey and in the U.S. Congress government, and included on a ballot referendum in November in Arizona. The Bill allows a terminally ill patient, and his or her treating physician, to decide if they will pursue treatment with an investigational drug, biological product or device, which has successfully completed Phase One of a clinical trial. This Bill does not obligate manufacturers to provide an investigational drug, biological product or device upon the patient’s request. It also does not obligate health insurance providers to cover the expenses of, or associated with, the use of an investigational drug, biological product or device. The Bill also protects all involved parties from being held liable for any loss, damage or injury that results from the use of investigational drug, biological product or device, and prevents state interference in the implementation of this policy.
Title
An Act To Amend Title 16 Of The Delaware Code Creating The Delaware "right To Try" Act.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2015-03-24 | Senate | Assigned to Health & Social Services Committee in Senate |
